Published in Histopathology on May 01, 1994
Pump-probe imaging of pigmented cutaneous melanoma primary lesions gives insight into metastatic potential. Biomed Opt Express (2015) 0.86
Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991. J Am Coll Surg (1995) 2.38
Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol (2004) 2.36
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol (2001) 2.15
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer (1998) 2.12
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
Resection margins for melanoma. Aust N Z J Surg (1985) 1.92
Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol (2000) 1.88
Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res (1995) 1.87
Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases. J Clin Pathol (2006) 1.72
Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg (1999) 1.68
Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol (2004) 1.64
Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. J Am Acad Dermatol (1992) 1.64
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology (1980) 1.61
Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol (1998) 1.57
Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Arch Dermatol (1996) 1.53
Prognostic significance of the histological features of malignant melanoma. Histopathology (1979) 1.51
Hepres genitalis; clinical and cytopathologic experience with 256 patients. Obstet Gynecol (1970) 1.42
Endocrine influences on survival from malignant melanoma. Cancer (1978) 1.40
Benefits of sentinel node biopsy for melanoma: a review based on interim results of the first Multicenter Selective Lymphadenectomy Trial. ANZ J Surg (2006) 1.39
Superior survival of young women with malignant melanoma. Am J Surg (1999) 1.39
Prognostic histopathological factors in malignant melanoma. Pathology (1985) 1.39
The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma. Cancer (1992) 1.38
Developments in surgical oncology--past, present, and future trends. Med J Aust (1992) 1.38
Immunological effects of solarium exposure. Lancet (1983) 1.38
Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck (2001) 1.30
Selection for contextual fear conditioning affects anxiety-like behaviors and gene expression. Genes Brain Behav (2007) 1.29
Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg (2000) 1.29
Microinvasive carcinoma of the uterine cervix. Am J Clin Pathol (1969) 1.28
Subungual melanoma of the hand. J Hand Surg Am (1996) 1.26
Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg (1991) 1.26
The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer (1985) 1.24
Previous pregnancy as a protective factor against death from melanoma. Lancet (1977) 1.23
Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer (1979) 1.22
Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol (1991) 1.22
Thin malignant melanomas and recurrence potential. Arch Surg (1987) 1.21
Voluntary ethanol drinking in C57BL/6J and DBA/2J mice before and after sensitization to the locomotor stimulant effects of ethanol. Psychopharmacology (Berl) (2001) 1.20
Naevus cells in lymph nodes. Pathology (1974) 1.20
Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I). Br J Surg (1980) 1.18
Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg (1992) 1.16
Late relapse from cutaneous stage I malignant melanoma. Arch Surg (1985) 1.16
Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer (1996) 1.15
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study. Br J Cancer (2010) 1.14
Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer (1980) 1.14
Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer (1980) 1.14
Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet (1988) 1.13
Non-subungual melanomas of the hand. J Hand Surg Br (1992) 1.13
Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. J Clin Pathol (2005) 1.13
Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Cancer Res (1984) 1.11
Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix. J Natl Cancer Inst (1981) 1.09
Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology (1983) 1.08
Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets. Q J Med (1987) 1.08
Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol (2000) 1.08
Malignant melanoma and vitiligo. Australas J Dermatol (1971) 1.07
Fine-needle-aspiration cytology in gynecologic oncology: "early detection of occult persistent or recurrent cancer after radiation therapy". Gynecol Oncol (1980) 1.06
Fine-mapping of muscle weight QTL in LG/J and SM/J intercrosses. Physiol Genomics (2010) 1.05
Occult primary malignant melanoma: factors influencing survival. Br J Surg (1977) 1.04
Fine mapping of QTL for prepulse inhibition in LG/J and SM/J mice using F(2) and advanced intercross lines. Genes Brain Behav (2010) 1.03
OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Genes Brain Behav (2010) 1.02
Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients. J Clin Oncol (1993) 1.02
Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg (1995) 1.00
Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Int J Cancer (1976) 1.00
Regulation of bile formation in rabbits and guinea pigs. Q J Exp Physiol Cogn Med Sci (1974) 0.99
Melanoma in New South Wales: an epidemiologic surgery 1970--76. Cancer (1980) 0.98
Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects. Br J Cancer (1983) 0.98
Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis. Genes Brain Behav (2012) 0.97
Papillary adenofibroma of the uterus: a benign mesodermal mixed tumor of Müllerian orgin. Am J Clin Pathol (1973) 0.97
Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med (1993) 0.97
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Am J Clin Pathol (1984) 0.96
Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer (1983) 0.96
A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes Brain Behav (2009) 0.96
Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1. Int J Cancer (2001) 0.96
Fine needle aspiration cytology in gynecologic oncology. I. Clinical aspects. Acta Cytol (1980) 0.95
The cellular detection of endometrial carcinoma and its precursors. Gynecol Oncol (1974) 0.95
Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients. Br J Cancer (1978) 0.95
Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol (1975) 0.94
Mixed carcinoma of the endometrium. Am J Obstet Gynecol (1968) 0.94
Multiple primary melanoma - a review of 90 cases. Australas J Dermatol (1982) 0.94
Acute and chronic responses to the convulsant pilocarpine in DBA/2J and A/J mice. Neuroscience (2007) 0.94
Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg (1984) 0.93